# Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration

> **NCT03714386** · NA · UNKNOWN · sponsor: **Fundación Senefro** · enrollment: 700 (estimated)

## Conditions studied

- Chronic Kidney Disease Requiring Chronic Dialysis

## Interventions

- **DEVICE:** A synthetic high-flux dialyzer will be used for OL-HDF.
- **DEVICE:** A medium cut-off dialyzer will be used for HDx.

## Key facts

- **NCT ID:** NCT03714386
- **Lead sponsor:** Fundación Senefro
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-03
- **Primary completion:** 2021-12
- **Final completion:** 2022-03
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2019-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714386, "Study to Explore Morbimortality in Patients Dialyzed With the Theranova HDx in Comparison to On-Line-Hemodiafiltration". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03714386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*